XETRA:DMP
Dermapharm Holding SE · XETRA · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 10:00 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
15.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
10.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
11.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
12.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.52Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.43 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.38x
Its own average over 10 years, 842.8M.
- Profit1.27x
Its own average over 10 years, 104.5M.
- Free cash flow1.10x
Its own average over 10 years, 126.8M.
- Debt1.73x
Its own average over 10 years, 609.2M.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 1.73 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 105.1 | 101.0 | 100.0 |
| 2018-12-31 | 128.8 | 97.8 | 99.2 |
| 2019-12-31 | 157.7 | 100.3 | 100.0 |
| 2020-12-31 | 178.6 | 111.5 | 100.0 |
| 2021-12-31 | 212.1 | 272.2 | 100.0 |
| 2022-12-31 | 230.6 | 174.3 | 100.0 |
| 2023-12-31 | 255.4 | 81.0 | 100.0 |
| 2024-12-31 | 265.7 | 147.8 | 100.0 |
| 2025-12-31 | 262.1 | 172.0 | 100.0 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
8.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate8.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Five-year EPS growth rate9.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
One-year change in net income16.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Returns on capital
10.3%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital10.3%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity19.1%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets6.0%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
33.6%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin33.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin19.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin11.4%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin12.0%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
15.4xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings15.4x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book3.0x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA9.2x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio1.8x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
1.52safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity1.52
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio2.05
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage4.2x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score2.20
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.4%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield2.4%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Payout ratio36.6%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio2.9x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.